These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors. Vocke CD, Yang Y, Pavlovich CP, Schmidt LS, Nickerson ML, Torres-Cabala CA, Merino MJ, Walther MM, Zbar B, Linehan WM. J Natl Cancer Inst; 2005 Jun 15; 97(12):931-5. PubMed ID: 15956655 [Abstract] [Full Text] [Related]
13. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer. Dong L, Gao M, Hao WJ, Zheng XQ, Li YG, Li XL, Yu Y. Medicine (Baltimore); 2016 May 15; 95(22):e3695. PubMed ID: 27258496 [Abstract] [Full Text] [Related]
14. Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families. Houweling AC, Gijezen LM, Jonker MA, van Doorn MB, Oldenburg RA, van Spaendonck-Zwarts KY, Leter EM, van Os TA, van Grieken NC, Jaspars EH, de Jong MM, Bongers EM, Johannesma PC, Postmus PE, van Moorselaar RJ, van Waesberghe JH, Starink TM, van Steensel MA, Gille JJ, Menko FH. Br J Cancer; 2011 Dec 06; 105(12):1912-9. PubMed ID: 22146830 [Abstract] [Full Text] [Related]
15. Intratumoral peripheral small papillary tufts: a diagnostic clue of renal tumors associated with Birt-Hogg-Dubé syndrome. Kuroda N, Furuya M, Nagashima Y, Gotohda H, Moritani S, Kawakami F, Imamura Y, Bando Y, Takahashi M, Kanayama HO, Ota S, Michal M, Hes O, Nakatani Y. Ann Diagn Pathol; 2014 Jun 06; 18(3):171-6. PubMed ID: 24767893 [Abstract] [Full Text] [Related]
16. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases. Petersson F, Gatalica Z, Grossmann P, Perez Montiel MD, Alvarado Cabrero I, Bulimbasic S, Swatek A, Straka L, Tichy T, Hora M, Kuroda N, Legendre B, Michal M, Hes O. Virchows Arch; 2010 Apr 06; 456(4):355-65. PubMed ID: 20300772 [Abstract] [Full Text] [Related]
17. Novel mutations in the BHD gene and absence of loss of heterozygosity in fibrofolliculomas of Birt-Hogg-Dubé patients. van Steensel MA, Verstraeten VL, Frank J, Kelleners-Smeets NW, Poblete-Gutiérrez P, Marcus-Soekarman D, Bladergroen RS, Steijlen PM, van Geel M. J Invest Dermatol; 2007 Mar 06; 127(3):588-93. PubMed ID: 17124507 [Abstract] [Full Text] [Related]
18. Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome. Iribe Y, Kuroda N, Nagashima Y, Yao M, Tanaka R, Gotoda H, Kawakami F, Imamura Y, Nakamura Y, Ando M, Araki A, Matsushima J, Nakatani Y, Furuya M. Pathol Int; 2015 Mar 06; 65(3):126-32. PubMed ID: 25597876 [Abstract] [Full Text] [Related]
19. Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia. Toro JR, Glenn G, Duray P, Darling T, Weirich G, Zbar B, Linehan M, Turner ML. Arch Dermatol; 1999 Oct 06; 135(10):1195-202. PubMed ID: 10522666 [Abstract] [Full Text] [Related]
20. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome. Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM. Am J Hum Genet; 2005 Jun 06; 76(6):1023-33. PubMed ID: 15852235 [Abstract] [Full Text] [Related] Page: [Next] [New Search]